Open AccessThe Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?
Author(s) -
Ameet Sarpatwari,
Aaron S. Kesselheim
Publication year - 2016
Publication title -
plos medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.847
H-Index - 228
eISSN - 1549-1676
pISSN - 1549-1277
DOI - 10.1371/journal.pmed.1001955
Subject(s) - trademark , brand names , business , drug approval , drug , drug industry , generic drug , medicine , advertising , political science , pharmacology , microbiology and biotechnology , law , biology
Ameet Sarpatwari and Aaron Kesselheim explore whether stripping branded drugs of trademark protection would improve the efficiency and fairness of health care.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom